Active Biotech AB (OSTO:ACTI) Payments of Debt: kr-1.20 Mil (TTM As of Mar. 2026)


OSTO:ACTI Active Biotech AB OSTO:ACTI
25 GF Score
Price kr5.30
! 1 Warning Sign
View Full Analysis

What is Active Biotech AB Payments of Debt?

Active Biotech AB OSTO:ACTI -0.38% 25 Payments of Debt is kr-1.20 Mil as of Mar. 2026. GuruFocus rates OSTO:ACTI with a GF Score™ of 25/100. The stock has 1 warning sign investors should review.

Active Biotech AB's Payments of Debt for the three months ended in Mar. 2026 was kr-0.40 Mil.

Active Biotech AB's Payments of Debt for the trailing twelve months (TTM) ended in Mar. 2026 was kr-1.20 Mil.

Active Biotech AB Payments of Debt Related Terms

Active Biotech AB Payments of Debt Historical Data

* Premium members only.

The historical data trend for Active Biotech AB's Payments of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Active Biotech AB Payments of Debt Chart

Active Biotech AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Payments of Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Active Biotech AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Payments of Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.40 -0.40 -0.40 0.00 -0.40
OSTO:ACTI
25GF Score
Active Biotech AB OSTO:ACTI
Payments of Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Active Biotech AB Payments of Debt Calculation

Payments of Debt represents all the cash outflow from debt, including both long-term debt and short-term debt.

Payments of Debt for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-1.20 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Payments of Debt →
What does a Payments of Debt of kr-1.20 Mil mean?
Active Biotech AB (OSTO:ACTI) has a Payments of Debt of kr-1.20 Mil as of Mar. 2026. Payments of Debt is all the cash outflow from debt, including both long-term debt and short-term debt. View historical data on Active Biotech AB and its competitors.
Is Active Biotech AB's Payments of Debt too high?
Active Biotech AB's current Payments of Debt is kr-1.20 Mil. Overall, Active Biotech AB has a GF Score™ of 25/100, reflecting its overall financial health beyond just this single metric.
How does Active Biotech AB's Payments of Debt compare to VRTX and REGN?
Active Biotech AB's Payments of Debt of kr-1.20 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Payments of Debt for a Biotechnology company?
A good Payments of Debt depends on the Biotechnology industry context. However, Payments of Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Payments of Debt mean?
A high Payments of Debt can signal that a stock is expensive relative to its fundamentals. Payments of Debt is all the cash outflow from debt, including both long-term debt and short-term debt. View historical data on Active Biotech AB and its competitors. Active Biotech AB's current Payments of Debt is kr-1.20 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Active Biotech AB stock overvalued right now?
Active Biotech AB (OSTO:ACTI) has a current Payments of Debt of kr-1.20 Mil. The current Payments of Debt is kr-1.20 Mil. Active Biotech AB's overall GF Score™ is 25/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Payments of Debt calculated?
Payments of Debt is calculated from a company's financial statements. For Active Biotech AB (OSTO:ACTI), the current Payments of Debt is kr-1.20 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Active Biotech AB Business Description

Other Exchanges 0GQU:UKBTP:Germany
Address Scheelevagen 22, P.O. Box 724, Lund, SWE, 223 63
Active Biotech AB focuses on the research and development of pharmaceuticals products within medical areas including neurodegenerative diseases, autoimmune/inflammatory disease and various forms of cancer. Its project portfolio contains both small molecules that are orally active immunomodulatory agents and antibody based immunotherapy. Its project portfolio includes both small orally active immunomodulatory molecules and antibody-based immunotherapy. Its pipeline products are: Tasquinimod, Laquinimod, and Naptumomab.
25GF Score

Get the complete analysis for OSTO:ACTI

Payments of Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr5.30
Price